|
Jun 3
|
How Moderna Went From Pandemic Hero to Vaccine Victim
|
|
Jun 2
|
These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, GM, Blueprint Medicines, BioNTech, DraftKings, and More
|
|
Jun 2
|
Two biopharma stocks to consider outside of Moderna
|
|
Jun 2
|
Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More
|
|
Jun 2
|
Tesla EU sales, FDA & Moderna, DraftKings: Trending Tickers
|
|
Jun 2
|
Moderna Stock Is Rising. A New Covid Vaccine Is Coming But Only for Some.
|
|
Jun 2
|
Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine
|
|
Jun 2
|
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
|
|
Jun 2
|
Moderna gains as FDA nod for next-gen COVID-19 vaccine
|
|
May 29
|
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
|
|
May 28
|
US cancels more than $700 million funding for Moderna bird flu vaccine
|
|
May 28
|
Moderna Announces Update on Investigational Pandemic Influenza Program
|
|
May 27
|
Moderna to Present at Upcoming Conferences in June 2025
|
|
May 26
|
Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”
|
|
May 26
|
MRNA Seeks FDA Nod for Updated COVID-19 Vaccine
|
|
May 26
|
COVID Vaccine Makers Catch a Break in FDA Policy Shift
|
|
May 23
|
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review
|
|
May 23
|
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
|
|
May 22
|
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
|
|
May 22
|
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot
|